Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 15 X posts from 10 X users, with an upper bound of 40,316 followers.

Great work @SbrtSean ! Well done 👍🏻.

RT @SbrtSean: Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate…

RT @sarthakshah097: Check out our most recent publication!

Check out our most recent publication!

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.